Document is current
Any future updates will be listed below
-
Authors
Rainio, Oona https://orcid.org/0000-0002-7775-7656
Latva-Rasku, Aino https://orcid.org/0000-0001-8786-9160
Hirvonen, Jussi https://orcid.org/0000-0002-0368-3746
Knuuti, Juhani https://orcid.org/0000-0003-3156-9593
Klén, Riku https://orcid.org/0000-0002-0982-8360
-
Funding
Funding for this research was provided by:
Otto A. Malm Lahjoitusrahasto
Sakari Alhopuron säätiö
Suomen Lääketieteen Säätiö
University of Turku
- License Information
-
More Information
Article History
Received: 7 February 2025
Revised: 25 April 2025
Accepted: 29 April 2025
First Online: 31 May 2025
Declarations
:
: J.K. received consultation fees from GE Healthcare and AstraZeneca and speaker fees from GE Healthcare, Bayer, Lundbeck, Boehringer-Ingelheim, Pfizer, Merck, and Siemens, outside the submitted work.
: All the patients were at least 18 years of age, consented to the use of their data, and the research from their data was approved by Ethics Committee of the Hospital District of Southwest Finland.
